Designed for the qualitative and semi-quantitative detection of cannabinoids in human urine, focusing on the major THC metabolite, 11-nor-9-THC-9-COOH (cTHC).
Utilizes a homogeneous enzyme immunoassay technology, providing a ready-to-use liquid reagent for streamlined processing.
Compatible with automated clinical chemistry analyzers, enhancing laboratory efficiency and throughput.
Suitable for a broad range of research and clinical applications, ensuring reliable detection of THC use.
